These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9468457)

  • 1. Altered action of angiotensin II in patients with type 2 diabetes mellitus of recent onset.
    Fliser D; Keller C; Bahrmann P; Franek E; Schreckling H; Bergis K; Ritz E
    J Hypertens; 1997 Mar; 15(3):293-9. PubMed ID: 9468457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opposing effects of angiotensin II on muscle and renal blood flow under euglycemic conditions.
    Fliser D; Dikow R; Demukaj S; Ritz E
    J Am Soc Nephrol; 2000 Nov; 11(11):2001-2006. PubMed ID: 11053475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin II enhances insulin sensitivity in healthy volunteers under euglycemic conditions.
    Fliser D; Arnold U; Kohl B; Hartung R; Ritz E
    J Hypertens; 1993 Sep; 11(9):983-8. PubMed ID: 8254181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pressor and subpressor doses of angiotensin II increase insulin sensitivity in NIDDM. Dissociation of metabolic and blood pressure effects.
    Morris AD; Petrie JR; Ueda S; Connell JM; Elliott HL; Small M; Donnelly R
    Diabetes; 1994 Dec; 43(12):1445-9. PubMed ID: 7958497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autonomy of the renin system in type II diabetes mellitus: dietary sodium and renal hemodynamic responses to ACE inhibition.
    De'Oliveira JM; Price DA; Fisher ND; Allan DR; McKnight JA; Williams GH; Hollenberg NK
    Kidney Int; 1997 Sep; 52(3):771-7. PubMed ID: 9291199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperglycemia and angiotensin-mediated control of the renal circulation in healthy humans.
    Osei SY; Price DA; Fisher ND; Porter L; Laffel LM; Hollenberg NK
    Hypertension; 1999 Jan; 33(1 Pt 2):559-64. PubMed ID: 9931165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of insulin and lipid emulsion on renal haemodynamics and renal sodium handling in IDDM patients.
    Pelikánová T; Smrcková I; Krízová J; Stríbrná J; Lánská V
    Diabetologia; 1996 Sep; 39(9):1074-82. PubMed ID: 8877292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal function in the AT1A receptor knockout mouse during normal and volume-expanded conditions.
    Cervenka L; Mitchell KD; Oliverio MI; Coffman TM; Navar LG
    Kidney Int; 1999 Nov; 56(5):1855-62. PubMed ID: 10571794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose iloprost infusion improves insulin action in aged healthy subjects and NIDDM patients.
    Paolisso G; Di Maro G; D'Amore A; Passariello N; Gambardella A; Varricchio M; D'Onofrio F
    Diabetes Care; 1995 Feb; 18(2):200-5. PubMed ID: 7537193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal responses to angiotensin II infusion in early type 1 (insulin-dependent) diabetes.
    Eadington DW; Swainson CP; Frier BM; Semple PF
    Diabet Med; 1991 Jul; 8(6):524-31. PubMed ID: 1832351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Losartan modifies glomerular hyperfiltration and insulin sensitivity in type 1 diabetes.
    Nielsen S; Hove KY; Dollerup J; Poulsen PL; Christiansen JS; Schmitz O; Mogensen CE
    Diabetes Obes Metab; 2001 Dec; 3(6):463-71. PubMed ID: 11903420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-stimulated muscle glucose clearance in patients with NIDDM. Effects of one-legged physical training.
    Dela F; Larsen JJ; Mikines KJ; Ploug T; Petersen LN; Galbo H
    Diabetes; 1995 Sep; 44(9):1010-20. PubMed ID: 7657022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrarenal infusion of angiotensin-(1-7) modulates renal functional responses to exogenous angiotensin II in the rat.
    Bürgelová M; Kramer HJ; Teplan V; Velicková G; Vítko S; Heller J; Malý J; Cervenka L
    Kidney Blood Press Res; 2002; 25(4):202-10. PubMed ID: 12424421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of prostacyclin on renal haemodynamics, renal tubular function and vasoactive hormones in healthy humans. A placebo-controlled dose-response study.
    Nielsen CB; Bech JN; Pedersen EB
    Br J Clin Pharmacol; 1997 Nov; 44(5):471-6. PubMed ID: 9384464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of glimepiride on pancreatic beta-cell function under hyperglycaemic clamp and hyperinsulinaemic, euglycaemic clamp conditions in non-insulin-dependent diabetes mellitus.
    Clark HE; Matthews DR
    Horm Metab Res; 1996 Sep; 28(9):445-50. PubMed ID: 8911981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered aldosterone response to salt intake and angiotensin II infusion in young normotensive men with parental history of arterial hypertension.
    Schlaich MP; Klingbeil AU; Jacobi J; Delles C; Schneider MP; Schmidt BM; Schmieder RE
    J Hypertens; 2002 Jan; 20(1):117-24. PubMed ID: 11791034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin II affects basal, pulsatile, and glucose-stimulated insulin secretion in humans.
    Fliser D; Schaefer F; Schmid D; Veldhuis JD; Ritz E
    Hypertension; 1997 Nov; 30(5):1156-61. PubMed ID: 9369270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of angiotensin converting enzyme inhibition and angiotensin II type 1 receptor antagonism on renal sodium and water handling and albuminuria during infusion of atrial natriuretic factor into healthy volunteers.
    Vervoort G; Hertenberg F; Wetzels JF; Smits P
    J Hypertens; 1998 Feb; 16(2):245-50. PubMed ID: 9535153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelin ETA receptor-subtype specific antagonism does not mitigate the acute systemic or renal effects of exogenous angiotensin II in humans.
    Bayerle-Eder M; Langenberger H; Pleiner J; Polska E; Mensik C; Eichler HG; Wolzt M; Schmetterer L
    Eur J Clin Invest; 2002 Apr; 32(4):230-5. PubMed ID: 11952807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term effects of liraglutide on kidney function and vasoactive hormones in type 2 diabetes: a randomized clinical trial.
    Skov J; Pedersen M; Holst JJ; Madsen B; Goetze JP; Rittig S; Jonassen T; Frøkiaer J; Dejgaard A; Christiansen JS
    Diabetes Obes Metab; 2016 Jun; 18(6):581-9. PubMed ID: 26910107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.